Skip to main content

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Rafael Simó Canonge

Institutions of which they are part

Head of group
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Neurodegeneración en la patogénesis de la retinopatía diabética incipiente. Estudio de los mecanismos impllicados a través de un abordaje integrado de biología de sistemas

IP: Rafael Simó Canonge
Collaborators: Dulce María Moncho Rodríguez, Ana Boixadera Espax, Marta Rosal Fontana, Miguel Angel Zapata Victori
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 181500
Reference: SAF2009-07408
Duration: 01/01/2010 - 31/12/2012

Ministerio de Ciencia

Grup de Recerca en Diabetis i Metabolisme

IP: Rafael Simó Canonge
Collaborators: Carles Zafon Llopis, Cristina Hernández Pascual, David Martinez Selva, Andreea Ciudin Mihai
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 43680
Reference: 2009 SGR 739
Duration: 01/01/2010 - 30/04/2014

Sex hormone-binding globulin (SHBG): Identification of the molecular mechanisms that regulate its expression and role in body fat distribution and in the development of type 2 diabetes

IP: David Martinez Selva
Collaborators: Rafael Simó Canonge, Cristina Hernández Pascual
Funding agency: Instituto de Salud Carlos III
Funding: 42000
Reference: CP08/00058
Duration: 01/01/2009 - 31/12/2011

Sex hormone-binding globulin (SHBG): Identification of the molecular mechanisms that regulate its expression and role in body fat distribution and in the development of type 2 diabetes

IP: Rafael Simó Canonge
Collaborators: David Martinez Selva, Miriam Izquierdo Sans
Funding agency: Instituto de Salud Carlos III
Funding: 247050
Reference: MS08/00058
Duration: 01/02/2009 - 31/01/2015

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

This investment from EIT Health in the project will enable D-Sight to progress in the clinical development of its groundbreaking treatment for the early stages of diabetic retinopathy.

This initiative of the ”la Caixa” Foundation offers the selected entrepreneurial scientists financial support and support through individual mentoring and training.

Related professionals

Betina Biagetti Biagetti

Betina Biagetti Biagetti

Diabetes and Metabolism
Read more
Mireia  Beltran  Porres

Mireia Beltran Porres

Growth and Development
Read more
Joana Ramis Garcia

Joana Ramis Garcia

Research technician
Pharmacokinetic Nanoparticles
Read more
Adrià  Tomé Cabello

Adrià Tomé Cabello

Medium Grade Technician
Technological Infrastructure Unit
Digital Transformation Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.